… diseases and kidney transplantation. The available therapeutic apheresis techniques used
in kidney diseases… Despite advances in understanding the pathogenesis, treatment regimens …

… Therapy of systemic autoimmune rheumatic diseases can still be a challenge for
clinicians despite enormous progress made in the last decades on the understanding of the …

… treatment, follow up or patients characteristic. In this review, we have searched literature
concerning ECP use in rheumatic diseases. … use of therapeutic apheresis in rheumatic diseases …

… modalities aremycophenolate mofetil, chlorambucil, dexamethasone-cyclophosphamide,
IVIG therapy, TPE, ECPand rituximab [2]. The rationale for using TPE in the treatment of PV …

… of such patients’ progress to ESRD without therapy with high dose immunosuppression …
used as an adjunct to conventional immunosuppressive therapy in patients with severe disease. …

… of apheresis medicine and other physicians who may need to utilize therapeutic apheresis
(TA) … author reviewed any new developments in the understanding, current management, and …

… use of therapeutic apheresis in human disease. The recommendations are mostly in line with
the “Guidelines on the Use of Therapeutic Apheresis … American Society for Apheresis (ASFA…

… In this paper we report therapeutic apheresis procedures including emergency … The use of
apheresis remains stable in rheumatology, a medical specialty in which therapeutic progress …

… developments in the understanding, current management, … therapies may trigger the use
of therapeutic apheresis. O. This … a rationale for therapeutic apheresis use in the disease and …

… , since more than 45 years, has led in combination with immunosuppressive therapies and/…
Therapeutic apheresis is accepted as supportive therapy in all severe renal diseases such as …